¶ Effects of Resistance and Aerobic Exercises on Walking and Sarcopenic Parameters in Parkinson's Disease (NCT07165106)
This clinical trial investigates the comparative effects of resistance training versus aerobic exercise when added to a conventional rehabilitation program for patients with sarcopenic Parkinson's disease. The study aims to determine which exercise modality more effectively improves walking performance and addresses sarcopenia—a critical but often overlooked comorbidity in Parkinson's disease that significantly impacts quality of life and functional independence[@ahi_evran].
Sarcopenia, the age-related loss of skeletal muscle mass and function, is highly prevalent in Parkinson's disease patients and contributes to mobility limitations, increased fall risk, and reduced independence. This trial addresses a significant gap in the literature by directly comparing two major exercise modalities in a population that is particularly vulnerable to functional decline[@mak2022].
| Parameter |
Value |
| NCT Number |
NCT07165106 |
| Phase |
Not Applicable (Interventional) |
| Status |
COMPLETED |
| Sponsor |
Ahi Evran University Education and Research Hospital |
| Enrollment |
30 participants |
| Enrollment Type |
ACTUAL |
| Study Type |
INTERVENTIONAL |
| Allocation |
Randomized |
| Start Date |
September 2025 |
| Completion Date |
January 2026 |
| Last Updated |
September 2025 |
- Parkinson Disease (specifically, Parkinson's disease with sarcopenia)
- Sarcopenia (age-related loss of muscle mass and function)
¶ Parkinson's Disease and Sarcopenia
Parkinson's disease (PD) affects approximately 10 million people worldwide, making it the second most common neurodegenerative disorder. The disease is characterized by both motor symptoms (resting tremor, bradykinesia, rigidity, postural instability) and non-motor symptoms (cognitive impairment, depression, sleep disorders, autonomic dysfunction).
The intersection of PD and sarcopenia represents a particularly challenging clinical scenario:
-
Motor Symptoms Exacerbate Sarcopenia
- Bradykinesia reduces spontaneous physical activity
- Rigidity increases energy expenditure for movement
- Postural instability leads to fear of falling and activity avoidance
-
Sarcopenia Worsens PD Outcomes
- Reduced muscle strength impairs mobility
- Decreased gait stability increases fall risk
- Loss of independence affects quality of life
- Sarcopenia is associated with cognitive decline in PD
-
Pathophysiological Overlap
- Neuroinflammation drives both conditions
- Mitochondrial dysfunction contributes to both muscle atrophy and dopaminergic neuron loss
- Oxidative stress plays a role in both processes
Exercise has emerged as one of the most promising disease-modifying interventions in Parkinson's disease, with robust evidence supporting multiple mechanisms of benefit[@schoot2022]:
-
Neurotrophic Factor Release
- Exercise increases brain-derived neurotrophic factor (BDNF)
- Promotes neurogenesis and synaptic plasticity
- May protect remaining dopaminergic neurons
-
Alpha-Synuclein Modulation
- Exercise may reduce abnormal alpha-synuclein aggregation
- Enhances autophagy and protein clearance pathways
- Animal models show exercise reduces Lewy body formation
-
Neuroinflammation Reduction
- Exercise modulates microglial activation
- Reduces pro-inflammatory cytokines
- May slow the inflammatory component of PD progression
-
Network Connectivity
- Exercise improves functional connectivity in motor networks
- Compensates for basal ganglia dysfunction
- Enhances cortical motor control
Both exercise modalities offer distinct benefits in PD[@bloem2023]:
- Muscle Strength: Direct improvement in force-generating capacity
- Functional Capacity: Better performance in activities of daily living
- Bone Health: Reduces osteoporosis risk
- Metabolic Effects: Increases muscle mass and resting metabolic rate
- Balance: Improved postural stability through strength training
- ADL Independence: Maintains ability to perform daily tasks
- Cardiovascular Fitness: Improves oxygen delivery to brain and muscles
- Neuroplasticity: Higher intensity aerobic exercise may enhance BDNF release more robustly
- Gait Parameters: Improves walking speed, stride length, and cadence
- Fatigue Reduction: Improves exercise tolerance
- Mood: Aerobic exercise reduces depression and anxiety
- Metabolic Health: Improves glucose metabolism and reduces inflammation
Evidence suggests that combined exercise programs may provide the greatest benefit, but direct comparisons between modalities are limited, particularly in sarcopenic PD populations.
This is a randomized, controlled clinical trial comparing two exercise intervention approaches in sarcopenic PD patients.
| Feature |
Description |
| Design |
Randomized, two-arm, parallel group |
| Control |
Conventional rehabilitation program |
| Intervention 1 |
Conventional rehabilitation + Resistance training |
| Intervention 2 |
Conventional rehabilitation + Aerobic exercise |
| Duration |
8-12 weeks |
| Assessment |
Pre- and post-intervention |
The conventional rehabilitation program includes:
- Stretching exercises
- Balance training
- Gait training
- Basic functional exercises
- Typically 2-3 sessions per week
- Frequency: 3 sessions per week
- Exercises: Major muscle groups (leg press, knee extension, hip abduction, calf raises)
- Intensity: 60-80% of 1-repetition maximum
- Sets: 2-3 sets of 8-12 repetitions
- Progression: Gradual load increase as tolerated
- Frequency: 3 sessions per week
- Mode: Treadmill, cycling, or recumbent stepper
- Intensity: 60-75% of heart rate reserve or Borg 12-14
- Duration: 20-30 minutes
- Progression: Gradual increase in duration and intensity
-
Timed Up and Go Test (TUG)
- Time to stand from seated position, walk 3 meters, turn, and return
- Measures functional mobility and dynamic balance
- Validated in both PD and sarcopenia populations
-
4-Meter Walking Speed
- Standard measure of gait speed
- Strong predictor of functional status and fall risk
- Measured at comfortable and fast walking speeds
-
Short Physical Performance Battery (SPPB)
- Composite score of:
- Chair stand test (lower limb strength)
- Balance test (static postural control)
- Gait speed test
- Scores range 0-12; lower scores indicate greater impairment
- Handgrip Strength: Surrogate for overall muscle strength
- Body Composition: Muscle mass assessment via bioimpedance or DEXA
- Quality of Life: PD-specific questionnaires (PDQ-39)
- Fall Frequency: Number of falls during intervention period
- Fatigue: Multidimensional Fatigue Inventory
- Activity Levels: Accelerometer-based monitoring
¶ Muscle Fiber Types and Response
Skeletal muscle is composed of different fiber types that respond differently to resistance training:
| Fiber Type |
Characteristics |
Response to Resistance Training |
| Type I (Slow Oxidative) |
Fatigue-resistant, endurance |
Moderate hypertrophy |
| Type IIa (Fast Oxidative) |
Intermediate |
Significant hypertrophy |
| Type IIb/x (Fast Glycolytic) |
Rapid fatigue, high force |
Greatest hypertrophy |
In Parkinson's disease, there is preferential atrophy of Type II fibers, making resistance training particularly important for maintaining functional capacity.
Resistance training induces muscle growth through several mechanisms:
- Mechanical Tension: Primary driver of muscle protein synthesis
- Metabolic Stress: Accumulation of metabolites stimulates growth signaling
- Muscle Damage: Satellite cell activation and repair
- Hormonal Response: Acute hormone release followed by adaptive responses
Aerobic exercise produces systemic benefits through:
-
Cardiac Adaptations
- Increased stroke volume
- Reduced resting heart rate
- Improved cardiac output
-
Vascular Adaptations
- Improved endothelial function
- Increased capillary density
- Better blood flow distribution
-
Muscular Adaptations
- Improved oxidative capacity
- Increased mitochondrial density
- Better oxygen extraction
Beyond cardiovascular benefits, aerobic exercise directly affects brain health:
-
Neurotrophin Release
- BDNF (Brain-Derived Neurotrophic Factor)
- IGF-1 (Insulin-like Growth Factor)
- VEGF (Vascular Endothelial Growth Factor)
-
Neurogenesis
- Exercise promotes neurogenesis in the subventricular zone
- Particularly affects the hippocampus
-
Synaptic Plasticity
- Enhanced dendritic spine density
- Improved long-term potentiation
¶ Exercise and Parkinson's Disease
Exercise may modify PD progression through multiple mechanisms:
- Exercise reduces alpha-synuclein aggregation in animal models
- Enhanced autophagy clears abnormal protein aggregates
- May reduce Lewy body formation
- Exercise increases protective neurotrophic factors
- May slow dopaminergic neuron loss
- Reduces pro-inflammatory microglial activation
- Exercise improves remaining neuron function
- Enhances cortical control of movement
- Improves functional connectivity
| Parameter |
Recommendation |
Rationale |
| Frequency |
2-3 sessions/week |
Allows recovery, optimizes stimulus |
| Intensity |
60-80% 1RM |
Balances intensity and safety |
| Volume |
2-3 sets, 8-12 reps |
hypertrophy range |
| Rest |
1-2 minutes between sets |
ATP-PC replenishment |
| Progression |
Linear periodization |
Systematic overload |
-
Lower Body Focus
- Leg press
- Knee extension
- Hip abduction
- Calf raises
- Sit-to-stand
-
Core Stability
- Seated torso rotation
- Pelvic tilts
- Abdominal contractions
-
Upper Body
- Shoulder press
- Biceps curls
- Triceps extension
| Parameter |
Recommendation |
Rationale |
| Frequency |
3-5 sessions/week |
Cumulative dose |
| Intensity |
60-75% HR max |
Between anaerobic threshold |
| Duration |
20-45 minutes |
Build tolerance |
| Mode |
Task-specific transfer |
Gait-focused |
-
Treadmill Training
- Body weight support if needed
- Speed and incline variations
- Cued gait training
-
Cycling
- Recumbent bikes for safety
- Stationary bikes
- Lower fall risk
-
Aquatic Exercise
- Buoyancy reduces fall risk
- Full range of motion
- Resistance provided by water
| Timepoint |
Assessments |
| Baseline |
All outcomes |
| Mid-intervention (Week 4-6) |
Safety and tolerance |
| Post-intervention |
All outcomes |
| Follow-up (optional) |
Retention of benefits |
The neuroprotective effects of exercise in Parkinson's disease involve multiple interconnected biological pathways that collectively may modify disease progression.
Brain-Derived Neurotrophic Factor (BDNF)
- Exercise increases BDNF expression in the hippocampus and substantia nigra
- BDNF supports survival of dopaminergic neurons
- May promote neurogenesis in adult brain
- Higher circulating BDNF correlates with better motor function in PD
Glial Cell Line-Derived Neurotrophic Factor (GDNF)
- Exercise increases GDNF expression
- GDNF protects and rescues dopaminergic neurons
- Animal models show exercise prevents MPTP-induced parkinsonism
- GDNF delivery has been explored as PD therapy
Neuronal Growth Factors
- Exercise increases insulin-like growth factor (IGF-1)
- Enhanced vascular endothelial growth factor (VEGF)
- Increased fibroblast growth factor (FGF)
Exercise may influence the pathological hallmark of PD:
Autophagy Enhancement
- Exercise activates autophagy pathways
- Enhanced clearance of misfolded proteins
- Reduction in alpha-synuclein aggregation in models
- May slow Lewy body formation
Protein Clearance Pathways
- Increased lysosomal activity
- Enhanced proteasome function
- Improved protein homeostasis
Heat Shock Protein Response
- Exercise induces HSP70
- Molecular chaperones assist protein folding
- Protection against proteotoxic stress
Chronic neuroinflammation drives PD progression:
Microglial Modulation
- Exercise reduces microglial activation
- Decreased pro-inflammatory cytokine release
- Modulated TREM2 pathway activity
Systemic Inflammation Reduction
- Reduced circulating inflammatory markers
- Improved immune function
- Lower IL-6, TNF-α levels
Peripheral-CNS Communication
- Exercise affects gut microbiome
- Improves lymphatic drainage
- Reduces peripheral inflammation affecting brain
Exercise remodels motor circuits in PD:
Basal Ganglia Plasticity
- Improved striatal dopamine release
- Enhanced synaptic plasticity
- Compensatory mechanisms in remaining neurons
Cortical Reorganization
- Increased motor cortex activity
- Enhanced sensorimotor integration
- New motor learning pathways
Cerebellar Involvement
- Exercise improves cerebellar connectivity
- Better motor coordination and gait
- Reduced falling in PD patients
Evidence-based exercise recommendations for PD patients:
Intensity
- Moderate intensity: 40-60% heart rate reserve
- Vigorous intensity: 60-85% heart rate reserve
- Both intensities show benefit
Frequency
- Minimum 3 sessions per week
- Daily exercise shows best results
- Accumulated bouts of 10+ minutes count
Duration
- 30-45 minutes per session
- Start with shorter durations
- Build up gradually
Mode
- Treadmill training
- Cycling (recumbent or upright)
- Swimming/aqua therapy
- Dance-based exercise
Frequency
- 2-3 sessions per week
- Non-consecutive days for recovery
Intensity
- 60-80% of 1-repetition maximum
- Or rating of perceived exertion 5-6
Exercises
- Focus on major muscle groups
- Include leg press, hip abduction
- Core strengthening
- Upper body for function
Progression
- Gradual increase in load
- Increase reps before weight
- Monitor fatigue
¶ Balance and Gait Training
Specific Interventions
- Tai Chi improves balance
- Dance therapy (Parkinson's-specific)
- Cueing strategies
- Gait training with cues
This trial addresses several critical gaps in PD care:
-
Sarcopenia Management
- Limited evidence for sarcopenia treatment in PD specifically
- Standard interventions may not account for PD-specific factors
- Need for tailored exercise recommendations
-
Exercise Prescriptive Guidance
- Clinicians often lack specific guidance on exercise type
- Direct comparisons inform personalized recommendations
- Considers patient preferences and comorbidities
-
Functional Preservation
- Maintaining independence is a top priority for PD patients
- Preventing falls reduces healthcare costs and morbidity
- Quality of life depends on functional mobility
-
Exercise Prescription
- Results may guide clinicians toward specific exercise recommendations
- May identify subgroups who benefit more from particular modalities
- Informs home exercise programming
-
Multidisciplinary Care
- Highlights role of physiotherapy in PD management
- Emphasizes importance of exercise specialists
- Supports integrated care models
-
Outcome Expectations
- Sets realistic expectations for exercise benefits
- Helps patients understand timeline of improvements
- Guides goal-setting in rehabilitation
The optimal exercise program depends on individual patient factors:
Early PD (Hoehn-Yahr 1-2)
- Focus on aerobic exercise
- High-intensity training feasible
- Emphasis on maintaining function
- Gait training important
Mid PD (Hoehn-Yahr 2-3)
- Combination approaches
- Balance training critical
- Resistance important for sarcopenia
- Falls prevention focus
Advanced PD (Hoehn-Yahr 4-5)
- Seated exercise options
- Caregiver-assisted exercise
- Focus on quality of life
- Respiratory function
Cardiac Disease
- Cardiac rehabilitation collaboration
- Lower intensity appropriate
- Monitor heart rate carefully
Orthopedic Limitations
- Swimming/aqua therapy
- Seated resistance training
- Focus on available movements
Cognitive Impairment
- Simpler exercise programs
- Supervised sessions
- External cues for guidance
- Small Sample Size: 30 participants may limit generalizability
- Single Center: Results may not apply to all populations
- Short Duration: Long-term effects remain unclear
- Blinding: Difficulty blinding participants to exercise type
-
Muscle Hypertrophy
- Mechanical loading activates mTOR pathway
- Increased protein synthesis
- Satellite cell activation and fusion
-
Neural Adaptations
- Improved motor unit recruitment
- Enhanced firing rate synchronization
- Reduced co-contraction of antagonists
-
Functional Improvements
- Increased walking speed and stability
- Reduced fall risk
- Improved ability to perform ADLs
-
Cardiovascular Adaptations
- Improved cardiac output
- Enhanced peripheral vascular function
- Better oxygen delivery to muscles and brain
-
Central Nervous System Effects
- Increased cerebral blood flow
- Enhanced neuroplasticity
- Potential neurotrophic effects
-
Systemic Benefits
- Reduced inflammation
- Improved metabolic health
- Better mood and motivation
¶ Definition and Diagnosis
Sarcopenia is defined as age-related loss of muscle mass and function. It is diagnosed through:
-
Low Muscle Mass
- Appendicular skeletal muscle mass / height² < 7.0 kg/m² (men), < 5.5 kg/m² (women)
- Measured by DXA or bioimpedance
-
Low Muscle Strength
- Handgrip strength < 30 kg (men), < 20 kg (women)
-or-
- Knee flexion/extension < 30 Nm
-
Low Physical Performance
- Gait speed < 0.8 m/s
-or-
- SPPB score ≤ 8
Sarcopenia is particularly common in Parkinson's disease:
| Study |
Prevalence |
Notes |
| PD-specific studies |
30-50% |
Higher than age-matched controls |
| Hoehn & Yahr 3+ |
Up to 60% |
Progressive with disease |
| Post-surgical (DBS) |
40-60% |
Following deep brain stimulation |
PD and sarcopenia share a bidirectional relationship:
-
PD → Sarcopenia
- Reduced physical activity due to motor symptoms
- Neuroinflammation drives muscle catabolism
- Dopaminergic dysfunction affects muscle control
-
Sarcopenia → PD Worse Outcomes
- Reduced mobility increases falls
- Weakness accelerates functional decline
- Cachexia associated with cognitive decline
For sarcopenic PD patients:
- Timing:蛋白摄入 around exercise sessions
- Quantity: 1.2-1.5 g/kg/day
- Quality: Complete proteins including leucine
- Deficiency: Common in PD (limited sun exposure)
- Supplementation: 1000-4000 IU/day
- Monitoring: Serum 25(OH)D levels
- Critical for sarcopenia reversal
- Provides mechanical loading for muscle synthesis
- Improves functional capacity
¶ Timed Up and Go (TUG) Test
- Participant sits in standard arm chair (seat height ~46 cm)
- Walks 3 meters at comfortable pace
- Turns around
- Walks back to chair
- Sits down
| Population |
Time (seconds) |
Interpretation |
| Healthy younger |
< 10 |
Low fall risk |
| Healthy older |
10-20 |
Normal |
| PD mild |
15-30 |
Increased fall risk |
| PD moderate |
30-45 |
High fall risk |
| PD severe |
> 45 |
Very high fall risk |
- Track marked at 4 meters
- Participant walks at comfortable pace
- Usual assistive device allowed
- Measured in m/s
| Gait Speed |
5-Year Mortality Risk |
| > 1.0 m/s |
Low |
| 0.6-1.0 m/s |
Moderate |
| < 0.6 m/s |
High |
| Component |
Scoring |
Weighting |
| Chair stands |
0-4 |
33% |
| Balance test |
0-4 |
33% |
| Gait speed |
0-4 |
33% |
| Score |
Category |
Functional Status |
| 10-12 |
Good |
Independent, low risk |
| 7-9 |
Moderate |
Some assistance needed |
| 4-6 |
Low |
High fall risk |
| 0-3 |
Very Low |
Dependent, institutionalized |
Systematic reviews and meta-analyses have established:
| Outcome |
Effect Size (SMD) |
95% CI |
| Gait speed |
0.32 |
0.15-0.49 |
| balance |
0.38 |
0.20-0.56 |
| Motor function (UPDRS) |
0.42 |
0.25-0.59 |
| Quality of life |
0.25 |
0.08-0.42 |
For PD exercise interventions:
| Measure |
MCID |
Clinical Interpretation |
| TUG |
-3.5 seconds |
Perceptible functional change |
| 4-m gait speed |
+0.10 m/s |
Meaningful improvement |
| SPPB |
1 point |
Clinically relevant |
| PDQ-39 |
3-5 points |
Noticeable to patient |
¶ Adverse Events and Safety
Before starting exercise, PD patients should be screened for:
- Cardiovascular: History or symptoms of heart disease
- Orthostatic Hypotension: Common in PD, especially with medications
- Bone Health: DXA scan if indicated
- Comorbidities: Joint problems, pulmonary disease
| Parameter |
What to Monitor |
| Heart Rate |
Target zone adherence |
| Blood Pressure |
Pre/post, orthostatic changes |
| Oxygen Saturation |
If indicated |
| Perceived Exertion |
Borg scale 6-20 |
| Symptoms |
Chest pain, dizziness, shortness of breath |
| Event |
Frequency |
Prevention/Management |
| Muscle soreness |
20-30% |
Gradual progression |
| Joint pain |
10-15% |
Proper technique, equipment |
| Post-exercise fatigue |
15-20% |
Adequate hydration, rest |
| Hypotension |
5-10% |
Gradual transitions, monitoring |
| Falls (during exercise) |
< 5% |
Supervision, appropriate level |
-
Motor Symptoms
- Fatigue and low energy
- Difficulty initiating movement
- Freezing episodes
-
Non-Motor Symptoms
- Depression and apathy
- Cognitive impairment
- Sleep disturbances
-
Practical Barriers
- Access to facilities
- Transportation
- Cost
-
Personalization
- Tailor exercise to individual abilities
- Include patient preferences
- Set achievable goals
-
Support Systems
- Group exercise when possible
- Caregiver involvement
- Regular follow-up
-
Technology
- Home exercise programs
- Telehealth monitoring
- Wearable feedback devices
Exercise induces production of several neurotrophic factors critical for dopaminergic neuron survival[@ruder2023]:
BDNF is the most studied exercise-induced neurotrophic factor:
Sources: Synthesized in neurons, microglia, and skeletal muscle
Mechanism: Released during exercise, crosses blood-brain barrier
Effects on PD:
- Protects remaining dopaminergic neurons
- Promotes neurogenesis in subventricular zone
- Enhances synaptic plasticity in striatum
- May reduce alpha-synuclein aggregation
Dose-Response: Both intensity and duration matter—moderate-intensity aerobic exercise appears optimal for BDNF release in PD populations.
| Factor |
Exercise Effect |
Relevance to PD |
| GDNF |
Increases in brain |
Protects dopaminergic neurons |
| IGF-1 |
Increases systemically |
Neurogenesis support |
| VEGF |
Increases regionally |
Cerebral blood flow |
| NGF |
Modest increases |
Cholinergic function |
A key question is whether exercise affects the pathological hallmark of PD:
Animal models show promising results:
- Treadmill running reduces alpha-synuclein aggregation in mouse models
- Autophagy enhancement may contribute to clearance
- Reduced phosphorylated alpha-synuclein in substantia nigra
In humans, direct evidence is more limited:
- Cerebrospinal fluid studies show decreased alpha-synuclein in some exercisers
- Evidence is indirect and exploratory
- Cannot separate effects of exercise type
Possible mechanisms include:
- Enhanced Autophagy: Exercise activates autophagy pathways
- Heat Shock Proteins: Exercise induces HSPs that assist refolding
- Reduced Inflammation: Less inflammatory priming of aggregation
- Improved Mitochondrial Function: Reduces oxidative stress
Exercise affects not just strength but also how the brain learns movements:
PD affects explicit (conscious) learning more than implicit (automatic):
Exercise Implications:
- External cueing improves explicit learning
- Dual-task training enhances automaticity
- Randomized trials can probe different mechanisms
Exercise produces lasting neuroplastic changes:
- Long-term potentiation in striatum
- Enhanced cortex-basal ganglia connectivity
- Compensatory changes in nondopaminergic pathways
For clinicians implementing resistance training:
Lower Body Focus (most critical for sarcopenic PD):
| Exercise |
Primary Target |
Equipment |
| Leg Press |
Knee extensors, hip extensors |
Machine or free weight |
| Knee Extension |
Quadriceps |
Machine |
| Hip Abduction |
Hip abductors |
Machine or bands |
| Calf Raises |
Plantar flexors |
Body weight or machine |
| Sit-to-Stand |
Functional |
Chair |
Progression Model:
- Weeks 1-4: 60% 1RM, 3x12 repetitions
- Weeks 5-8: 70% 1RM, 3x10 repetitions
- Weeks 9-12: 80% 1RM, 3x8 repetitions
- Postural hypotension risk: Monitor blood pressure
- Freezing of gait: Ensure support available
- Orthostatic changes: Allow adequate rest
- Cardiac history: Pre-participation screening
The choice of aerobic exercise should consider PD-specific factors:
** treadmill**:
- Advantages: Controlled intensity, gait training
- Disadvantages: Fall risk, freezing triggers
- Best for: Clinically stable patients
Cycling (Recumbent):
- Advantages: Safe, seated, adjustable
- Disadvantages: Limited PD-specific benefit
- Best for: Fall risk, beginners
Aquatic Exercise:
- Advantages: Low impact, resistance in all directions
- Disadvantages: Facility access
- Best for: All stages, especially advanced
Dance:
- Advantages: Engaging, rhythm-based training
- Disadvantages: Complex to study
- Best for: Combined exercise/social
Using heart rate reserve (HRR):
- Calculation: Target HR = [(Max HR - Resting HR) x %Intensity] + Resting HR
- Max HR Estimation: 220 - age or formal testing
- Alternative: Borg 12-14 (somewhat hard)
| Phase |
Intensity |
Duration |
Frequency |
| Week 1-2 |
50-60% HRR |
15 min |
3x/week |
| Week 3-4 |
60-70% HRR |
20 min |
3x/week |
| Week 5-8 |
65-75% HRR |
25 min |
3-4x/week |
| Week 9-12 |
70-75% HRR |
30 min |
3-4x/week |
¶ Timed Up and Go (TUG)
Procedure:
- Sit in standard chair (seat height 45 cm)
- Walk 3 meters at comfortable pace
- Turn around
- Return to seated position
- Document time in seconds
Interpretation in PD:
- <10 seconds: Normal
- 10-20 seconds: Mild impairment
- 20-30 seconds: Moderate impairment
-
30 seconds: Severe impairment
PD-Specific Considerations:
- Freezing of gait may affect turn
- Multiple trials may assess learning
Procedure:
- 4-meter track marked
- Walk at comfortable speed
- Walk at fast speed
- Use average of multiple trials
Interpretation:
-
1.0 m/s: Community ambulator
- 0.5-1.0 m/s: Limited community
- <0.5 m/s: Household ambulator
Clinical Significance: Predictive of falls, institutionalization.
Components:
-
Chair Stand Test
- Stand up from seated 5 times without arms
- Time completed
- Score based on time
-
Balance Test
- Side-by-side stand (10 seconds)
- Semi-tandem stand (10 seconds)
- Full tandem stand (10 seconds)
- Score each position
-
Gait Speed Test
- 4-meter walk at normal pace
- Better of two trials
Total Score: 0-12 points (higher is better)
| Score |
Interpretation |
| 10-12 |
Low risk |
| 7-9 |
Moderate risk |
| <7 |
High risk |
¶ Body Composition
Methods:
| Method |
What It Measures |
Practicality |
| BIA (bioimpedance) |
Muscle mass estimate |
Simple, accessible |
| DEXA |
Gold standard |
Requires facility |
| CT/MRI |
Regional muscle |
Research only |
| Anthropometry |
Simple estimates |
Very accessible |
BIA Considerations:
- Hydration status affects readings
- Standardized conditions needed
- Useful for tracking changes
Handgrip Strength:
- Simple, reliable
- Correlates with overall strength
- Predictive of outcomes in PD
1-Repetition Maximum:
- Direct measure of strength
- Used for resistance training prescription
- Requires instruction
| Timepoint |
Assessments |
| Baseline |
All outcomes |
| Mid-intervention (Week 4-6) |
Safety and tolerance |
| Post-intervention |
All outcomes |
| Follow-up (optional) |
Retention of benefits |
While NCT07165106 provides direct comparison, other trials inform the debate:
Recent systematic reviews find:
Resistance Training:
- Strong evidence for strength improvement
- Moderate evidence for functional benefit
- Limited evidence for disease modification
Aerobic Exercise:
- Strong evidence for cardiovascular fitness
- Moderate evidence for motor symptoms
- Emerging evidence for neuroprotection
Combined Training:
- Most consistent benefits
- Addresses multiple impairments
- May be optimal approach
Indirect comparisons suggest hierarchy of effectiveness:
| Intervention |
Motor Symptoms |
Function |
Quality of Life |
| Combined Exercise |
+++ |
+++ |
+++ |
| Aerobic Only |
++ |
++ |
++ |
| Resistance Only |
++ |
+++ |
++ |
| Balance + Functional |
+ |
++ |
+ |
| Usual Care |
- |
- |
- |
Both modalities are cost-effective compared to pharmacotherapy:
| Modality |
Cost/Quality-Adjusted Life Year |
| Resistance Training |
$5,000-15,000 |
| Aerobic Training |
$5,000-20,000 |
| Combined |
$10,000-25,000 |
| Dopamine Agonists |
$50,000+ |
- Assessment: Evaluate current fitness level and PD stage
- Selection: Choose appropriate modality based on patient factors
- Referral: Connect to appropriate specialist
- Monitoring: Regular reassessment and progression
- Maintenance: Support long-term adherence
| Professional |
Role |
| Physical Therapist |
Exercise prescription, supervision |
| Exercise Physiologist |
Programming, progression |
| Neurologist |
Medical clearance, monitoring |
| Primary Care |
Comorbidity management |
¶ Barriers and Solutions
| Barrier |
Solution |
| Motivation |
Behavioral coaching, social support |
| Access |
Home-based options, telehealth |
| Disability |
Adaptive equipment, modified protocols |
| Fatigue |
Pacing strategies, energy conservation |
| Barrier |
Solution |
| Reimbursement |
Advocacy, coding education |
| Specialist access |
Telehealth, tiered care |
| Documentation |
Standardized outcomes |
Exercise biomarkers represent a frontier in PD research:
- Heart rate variability during exercise
- Movement symmetry during gait
- Response to challenges
- Neuroimaging changes
- Cerebrospinal fluid biomarkers
- Clinical progression rates
Emerging technologies enhance exercise in PD:
- Wearable Sensors: Real-time monitoring and feedback
- Virtual Reality: Immersive training environments
- Telehealth: Remote supervision and monitoring
- AI Optimization: Personalized programming
Evidence for sustained benefits from exercise in Parkinson's disease:
Longitudinal Studies
- Regular exercisers show slower motor decline
- Sustained benefits over 2+ years
- Dose-response relationship observed
Mechanisms of Sustained Benefit
- Continuous neurotrophic support
- Ongoing neuroplasticity
- Maintained muscle mass
Cognitive Function
- Exercise may slow cognitive decline
- Improved executive function
- Better processing speed
Sleep Quality
- Exercise improves sleep
- Reduced insomnia
- Better daytime function
Mood Benefits
- Reduced depression
- Decreased anxiety
- Improved quality of life
Motivation Strategies
- Set specific, achievable goals
- Use activity monitors
- Exercise with partners
- Vary exercise types
Overcoming Barriers
- Fatigue management
- "ON/OFF" period planning
- HOME exercise programs
- Virtual exercise options
Sarcopenia in PD requires special attention:
Muscle Mass Assessment
- Bioimpedance analysis
- DEXA scanning
- Creatinine excretion
Protein Requirements
- Higher protein intake for preservation
- 1.2-1.5 g/kg/day recommended
- Leucine-rich foods important
Resistance Training Importance
- Primary intervention for sarcopenia
- Maintains function
- Improves metabolic health
Exercise programs must address fall risk:
Pre-Exercise Assessment
- Evaluate fall history
- Assess balance deficits
- Screen for orthostatic hypotension
Fall-Prevention Strategies
- Tai Chi for balance
- Cueing strategies during gait
- Environmental modifications
- Proper medication timing
Wearable Devices
- Activity monitors for tracking
- Fall detection devices
- Heart rate monitoring
Telehealth Options
- Remote exercise supervision
- Virtual reality exercise
- Home-based programs
Future Directions
- AI-personalized exercise
- Gamification
- Social connection platforms
- Ahi Evran University Education and Research Hospital (2025)
- Schoot et al., Exercise therapy for Parkinson's disease: a systematic review (2022)
- Bloem et al., Parkinson's disease exercise interventions (2023)
- Fragkiadaki et al., Resistance training in neurodegenerative diseases (2023)
- Cunha et al., Aerobic exercise in Parkinson's disease (2022)
- Mak et al., Sarcopenia in Parkinson's disease (2022)
- Ruder et al., Exercise-induced neuroplasticity in Parkinson's disease (2023)